It blocks the release of acetylcholine by nerves in muscle tissue, resulting in relaxation of muscle tone
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Weeks 5-8, Weeks 9-12, Weeks 13-16 2 vials Weeks 5-8: About 10.5 mg used at 375 mcg/day
Some patients may experience: Anxiety about treatment effectiveness or side effects Mood changes related to dietary restrictions Stress associated with lifestyle modifications Improved self-esteem and body confidence as weight decreases These psychological factors can have profound effects on sexual desire, either positive or negative, depending on individual circumstances
GLUTATHIONE OVERVIEW Category: Tripeptide, Intracellular Thiol Antioxidant, Detoxification Cofactor How It Works: Glutathione (GSH) works through several key biochemical mechanisms, primarily centered on the reactive sulfhydryl group on its cysteine component
Michael Nauck, Head of Clinical Research at the Diabetes Division, St